Lannett Company, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 94   

Articles published

LCI 44.15 -0.72 (-1.60%)
price chart
FDA clears Lannett's generic eye drug
The FDA approves Lannett Company's (LCI +0.3%) Abbreviated New Drug Application (ANDA) for Dorzolamide Hydrochloride and Timolol Maleate Ophthalmic Solution, the therapeutic equivalent to the reference listed drug, Cosopt Ophthalmic Solution of ...
Drug Manufacturers � Specific & Generic
Lannett Co Inc was incorporated in 1942 under the laws of the Commonwealth of Pennsylvania, and reincorporated in 1991 as a Delaware corporation.
Update: Lannett Fiscal Q1 2015 Earnings (LCI)
Lannett reported fiscal Q1 2015 earnings and revenue estimates above analyst estimates despite the fact that results were preannounced on October 23.
SHAREHOLDER ALERT: Investigation on Behalf of Lannett Company, Inc ...
BENSALEM, Pa., Jul 16, 2014 (BUSINESS WIRE) -- Law Offices of Howard G. Smith announces that it is investigating potential claims on behalf of investors of Lannett Company, Inc. (�Lannett� or the �Company�) LCI, +2.83% The investigation concerns ...
Related articles »  
Philadelphia drug company subpoenaed, stock price falls
Lannett Co. Inc.'s stock price dropped more than 8 percent in mid-day trading Thursday after the Northeast Philadelphia generic pharmaceutical company announced that it was hit with a grand jury subpoena this week.
Deadline in Lawsuit for Investors in Lannett Company, Inc. Shares Announced ...
SAN DIEGO, Sept. 9, 2014 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit was filed on behalf of certain purchasers of shares of Lannett Company, Inc. (NYSE:LCI) over alleged Violations of Federal Securities Laws by ...
Related articles »  
EQUITY ALERT: Rosen Law Firm Reminds Lannett Company, Inc. Investors of ...
NEW YORK, Oct. 14, 2014 (GLOBE NEWSWIRE) -- The Rosen Law Firm reminds purchasers of Lannett Company, Inc. stock (NYSE:LCI) between September 10, 2013 and July 16, 2014, of the important October 27, 2014 lead plaintiff deadline in the class ...
Related articles »  
Insider Selling: Lannett Company CEO Sells 5000 Shares of Stock (LCI)
Lannett Company's revenue was up 103.8% compared to the same quarter last year. On average, analysts predict that Lannett Company will post $3.49 earnings per share for the current fiscal year.
5 Stocks: MannKind Corp. (NASDAQ:MNKD), IXYS Corp. (NASDAQ:IXYS ...  Property Mentor
Related articles »  
Insider Selling: Arthur P. Bedrosian Unloads 5000 Shares of Lannett Company ...
One investment analyst has rated the stock with a hold rating and five have given a buy rating to the company. The company presently has a consensus rating of �Buy� and an average price target of $57.25.
Related articles »  
Lannett Company CEO Arthur P. Bedrosian Sells 5000 Shares (LCI)
One equities research analyst has rated the stock with a hold rating and five have issued a buy rating to the company. The stock currently has a consensus rating of �Buy� and an average target price of $57.25.